Clinical Trial Update: a PMS on Safety Profile of Pramipexole in Chinese Parkinson Disease Patients

View source ↗

Summary

A completed post-marketing safety surveillance study assessing the safety profile of pramipexole in Chinese patients with Parkinson disease; results were posted…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Pramipexole (Mirapex) (pramipexole)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Parkinson Disease | Status: COMPLETED | Results posted: 2013-08-30